www.nytimes.com
5 months agoNew Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most
FDA approves groundbreaking gene therapies for sickle cell disease
Access to these therapies remains a challenge for patients in countries where sickle cell is prevalent [ more ]